HALO logo
halo search icon
Moderna, Inc.

US$48.12

Price Change Indicator
2.40 (5.25%)
Moderna, Inc.
MRNA · NAS

Moderna, Inc.

Start Trading MRNA for Free

US$48.12

Price Arrow2.40 (5.25%)
20/05/2026 04:00:01 PM
All-CompaniesAll-ConsensusALL-RecommendationsHALO 500HALO AllHALO Small
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Moderna, Inc. Overview

MRNA Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Very Weak

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Weak

Earnings

Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Strong

About MRNA

icon
icon

Telephone

1.617.714.6500

icon

Address

325 Binney Street, Cambridge, MA 02142

Description

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

MRNA Price Chart

Key Stats

Market Cap

US$18.14B

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 22.28 - 59.55

Trade Value (12mth)

US$88,025,923.00

1 week

-6.77%

1 month

-15.69%

YTD

48.15%

1 year

77.21%

All time high

497.49

Key Fundamentals

EPS 3 yr Growth

-134.20%

EBITDA Margin

-147.10%

Operating Cashflow

-$1,873m

Free Cash Flow Return

-17.40%

ROIC

-26.20%

Interest Coverage

-285.90

Quick Ratio

3.20

Other Data

Shares Outstanding (Fully Diluted)

395m

HALO Sector

Healthcare

Next Company Report Date

25-Feb-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

MRNA Announcements

Latest Announcements

DateAnnouncements
11 May 26
11 May 26
11 May 26
02 May 26
02 May 26

MRNA Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-12.34-9.27-7.25locklocklock
EPS (Fully Diluted)
 $locklocklocklock-12.34-9.27-7.25locklocklock
Growth
 %locklocklocklock-158.124.921.8locklocklock
PE
 Xlocklocklocklock161.2N/AN/Alocklocklock
EV/EBITDA
 Xlocklocklocklock64.7N/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Moderna, Inc. (MRNA:NAS)?
Halo FAQ
The current share price of Moderna, Inc. (MRNA:NAS) is USD$48.12.
What is the 52-week high share price for Moderna, Inc. (MRNA:NAS)?
Halo FAQ
The 52-week high share price for Moderna, Inc. (MRNA:NAS) is USD$59.55.
What is the 52-week low share price for Moderna, Inc. (MRNA:NAS)?
Halo FAQ
The 52-week low share price for Moderna, Inc. (MRNA:NAS) is USD$22.28.
What is the dividend yield for Moderna, Inc. (MRNA:NAS)?
Halo FAQ
Moderna, Inc. (MRNA:NAS) does not pay a dividend.
What was Moderna, Inc. (MRNA:NAS) last dividend payment?
Halo FAQ
Moderna, Inc. (MRNA:NAS) does not pay a dividend.
What is the franking level for Moderna, Inc. (MRNA:NAS)?
Halo FAQ
Moderna, Inc. (MRNA:NAS) has a franking level of 0.00%.
In which sector is Moderna, Inc. (MRNA:NAS) classified?
Halo FAQ
Moderna, Inc. (MRNA:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial